FDA approves Ortho Evra’s new warning label
Johnson & Johnson, the makers of the Ortho Evra (norelgestromin/ethinyl estradiol) birth control patch, has updated the drug’s warning label to include new data on the odds ratio estimates of venous thromboembolism risk in women on Ortho Evra compared to users of oral contraceptives. The new label was approved by the Food and Drug Administration (FDA).
![[ Beasley Allen Law Firm Logo ]](http://www.orthoevra-legal.com/wp-content/themes/system-unity/images/logo.png)
Alisha Gutcher was just 24 years old when she suffered from chest pains and lightheadedness. “My heart was just freaking out,” she said to the
Leslie Niedner can’t make sense of the death of her 17-year-old daughter Adrianna. She was a healthy and active college freshman. It was later revealed that what killed her was a blood clot in her lung, also known as a pulmonary embolism. But how could such a condition happen to someone so young and healthy?
A
Johnson & Johnson, the makers of the
A British survey suggests one in three women spend no more than five minutes selecting a suitable contraceptive method to use, according to